Avoid unplanned shutdowns of pharmaceutical processes
Companies involved in pharmaceutical production must ensure tight controls on product purity through every stage of the manufacturing process. Due to the tight restrictions that the FDA and other regulatory agencies place on these companies, a single contaminated batch of a standard high-volume drug can result in substantial revenue loss. That is why hygienic clamps must not only prevent leaks, but they must not be susceptible to galling which can halt operations and risk process contamination.
Our white paper, How to Eliminate Clamp Galling, explains galling, its causes and how to avoid the problem. The white paper:
- Introduces galling and the problems it causes
- Describes how stainless steel is susceptible to galling
- Some strategies to reduce the risk of galling
- Use of a stainless-steel alloy with excellent resistance to galling even under high temperatures or high impact operations.
You will learn:
- Why clamp galling is a dangerous and a high-cost problem
- Use of procedures to avoid galling
- A novel solution to the risk of galling in a pharmaceutical process.
Download the white paper and reduce the risk of process contamination and unplanned shutdowns from sanitary clamps.